Jayasree Iyer – CEO, Access to Medicine Foundation
Speaking to PharmaBoardroom in the context of our upcoming InFocus special report on HIV, Access to Medicine Foundation CEO Jayasree Iyer looks back on pharma’s successes and failures in access…
Address: Minervum 7061, 4817 ZK, Breda,Netherlands
Tel: 076-5732500
Web: http://www.amgen.nl/dutch/index.html
Sinds 1997 levert Amgen vanuit Breda haar producten door heel Europa en aan een groeiend aantal landen in andere delen van de wereld. We verpakken medicijnen landenspecifiek, slaan ze tijdelijk op en verschepen uiteindelijk naar meer dan 50 landen.
Voor Amgen Europe B.V. geldt: “Elke patiënt, telkens weer”. Hiermee bedoelen we dat we ernaar streven om onze producten altijd beschikbaar te hebben op de juiste plaats en op de juiste tijd voor de behandeling van de patiënt. Vanuit Breda distribueren we zowel geregistreerde producten als producten die gebruikt worden in klinisch onderzoek. Breda is ook de vestigingsplaats van twee onderdelen van de Global Supply Chain organisatie verantwoordelijk voor Europa, Afrika en Australië/Nieuw-Zeeland. Daarnaast is Amgen Breda het internationale centrum buiten de Verenigde Staten voor enkele andere functies, zoals Quality & Regulatory Compliance, Information Systems en Financial Shared Services.
Circa 500 gemotiveerde mensen werken samen in hun streven naar perfectie in hun werkzaamheden, met als uiteindelijke doel het verbeteren van mensenlevens.
Amgen has marketed various key breakthrough products including Aranesp, Neulasta, Neupogen, Mimpara en Nplate all of which have made a vital contribution to patients’ welfare. Amgen’s future aims will also remain centred on finding innovative solutions for patients. This is why Amgen continues to develop new products for syndromes where treatment options are insufficient.
Speaking to PharmaBoardroom in the context of our upcoming InFocus special report on HIV, Access to Medicine Foundation CEO Jayasree Iyer looks back on pharma’s successes and failures in access…
Marijn Verhoef, Director of Operations and Research at the Access to Medicine Foundation examines the interconnected challenges of drug shortages and antimicrobial resistance. Verhoef urges decisive and urgent action from…
The EMA’s Peter Arlett looks back on two years of the Accelerating Clinical Trials in the European Union (ACT EU) initiative which aims to improve the environment for clinical trials…
New methodology for the 2024 Access to Medicine Index promises a stronger attempt to quantify whether drugs, vaccines, and diagnostics are actually making it all the way to patients in…
Claudia Martínez, generic & biosimilar medicines programme manager at the Access to Medicine Foundation, draws from a recent AMF report to outline what more generics companies can be doing to…
As part of a wide-ranging conversation with PharmaBoardroom published earlier this month, European Medicines Agency (EMA) Executive Director Emer Cooke laid out four of the Agency’s core focus areas for…
In conversation at DIA Europe 2023 in Basel, European Medicines Agency Executive Director Emer Cooke looks back at the lessons EMA has taken from the COVID-19 pandemic response, outlines the…
The Access to Medicine Index, a biennial report that gauges the efforts of the world’s largest pharma companies to expand access in low- and middle-income countries (LMICs), found in this…
The latest news from the Dutch pharma, biotech and healthcare industries, including the bullish comments of Argenx CEO Tim Van Hauwermeiren following the successful launch of its Vyvgart product; cancer…
The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use within the European Union, concluded a vote on Monday evening in Brussels following…
Leo de Haan of Aurobindo discusses how to maintain a profitable business in times of rock-bottom generics prices in the Netherlands, the resulting second pillar of specialty products for the…
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by Schering Plough, the Netherlands nevertheless still sits in fourth position on the 2015…
See our Cookie Privacy Policy Here
